abstract |
The present invention relates to a new use of phosphatidylcholine, and more particularly to a composition for toxicity reduction of an anti-cancer agent, and an anti-cancer adjuvant, comprising phosphatidylcholine as an active ingredient. The composition of the present invention can reduce toxicity of an anti-cancer agent while inhibiting or minimizing various side-effects occurring by the toxicity of the anti-cancer agent during chemical therapy of cancer. Thus, it is effective as an anti-cancer adjuvant. |